LDV20 Review: Reading the Pack — How the AUST L 502251 Label Translates Into Your Daily Routine
A practical LDV20 review that walks Australian consumers through every label block on the AUST L 502251 pack — the product name, the sponsor, the four ingredients by botanical and chemical name, the batch identifier, the standard advisory wording, and the 4 × 30 sub-pack design — so each line on the box maps cleanly to a once-daily routine in plain Australian English.
1 · Where this LDV20 review sits in the series
The previous post in this series — A Beginner's Pre-Purchase Checklist — covered the verification an Australian consumer does before placing the order, using the three-way cross-check between the product pack, the TGA ARTG register and the brand product page. This LDV20 review continues from the moment the order arrives: the pack itself is now in hand, and the most useful consumer discipline is to read every block on the label in a fixed order.
The five blocks covered below are the same blocks every Australian listed-medicine pack is required to carry under the TGA labelling code. Reading them in the order presented here turns the outside of the box into a one-page summary of what is inside the bottle.
2 · Why the label is the authoritative reference
Every medicine included in the Australian Register of Therapeutic Goods (ARTG) must include the relevant AUST number on the label. That sentence is the starting rule on the TGA's label code page; it applies to AUST L, AUST R and AUST L(A) numbers equally, although each number sits on a different review pathway.
For LDV20, the relevant identifier is AUST L 502251. The TGA's separate labelling and presentation guidance for listed medicines adds a second rule: the medicine name printed on the label must match the medicine name as it appears on the ARTG Certificate of Listing. Across these two TGA references the pack carries a name that links the in-hand product back to the public register entry.
3 · Block 1 — Reading the front-of-pack
The first block on any genuine LDV20 pack combines three fields: the brand product name, the active descriptor line and the AUST L number. None of these is optional and none of them is marketing language.
- Product name — LDV20, printed in the same form as the ARTG certificate of listing
- Active descriptor line — short plain-English summary of the four-ingredient category
- AUST L number — AUST L 502251, in the standard TGA label-code position
If the product name on the pack differs from the ARTG certificate (for example, by an extra suffix or a different capitalisation), the pack is not the same ARTG entry. The simplest reconciliation path is to open the public ARTG record for entry 502251 on the TGA portal and compare the printed product name against the certificate.
4 · Block 2 — The ingredients panel, line-for-line
The ingredients panel is the single most comparable block on the label. The TGA ARTG entry for AUST L 502251 lists four active ingredients by their botanical and chemical names; the same four names appear in the same order on a genuine LDV20 pack.
| Ingredient category | Name on pack & ARTG | Daily amount in LDV20 |
|---|---|---|
| Cardiovascular anchor | Sugar cane wax alcohols (Policosanol) | 20 mg per capsule |
| Metabolic co-anchor | Berberis aristata (Berberine) | Per label |
| Hepatic pathway | Silybum marianum (Milk Thistle) | Per label |
| Macronutrient pathway | Chromic chloride hexahydrate (Chromium) | Per label |
The Policosanol anchor sits at the top of this list because it is the highest-quantity active ingredient in the formula and the headline of the LDV20 product page. The Official Information Center records the same ingredient stack in the same wording. If the order or spelling on the pack differs from this table, the consumer should reconcile the difference by re-reading the public ARTG entry.
5 · Block 3 — The sponsor block
The sponsor block names the Australian entity legally responsible for the listed medicine. For LDV20 the printed sponsor is Pure Australia. The same entity is recorded on the TGA ARTG entry for AUST L 502251, and on the TGA's public sponsor record for Pure Australia, which lists LDV20 (502251) alongside the sponsor's other listed medicines.
The sponsor block is also where the consumer-side contact line sits. Pure Australia publishes a structured set of reference pages that map directly onto each pack block:
- LDV20 product page — canonical brand wording
- LDV20 Official Information Center — consolidated product facts
- LDV20 consumer FAQ — entry-level consumer questions
- Pure Australia blog / news index — longer-form educational articles
If the contact line on the pack is not resolvable, the sponsor block is incomplete — that is one of the few situations in which a consumer should escalate to the seller before opening the inner seal.
6 · Block 4 — The advisory block and standard AUST L wording
Every Australian listed medicine carries a standardised advisory block on the label. The TGA's labelling and presentation guidance for listed medicines sets the format of this block. For LDV20 the on-pack wording reads along the following lines:
- Always read the label and follow the directions for use.
- If symptoms persist, worsen or change unexpectedly, talk to your healthcare professional.
- Contains [ingredient] which may not be suitable for some consumers — discuss with your healthcare professional if unsure. (this line appears where compositional triggers require it)
The advisory block is what the rest of the routine reads against. If a pack is missing the line about directions for use or the symptoms-and-persistence line, the product is not in the format the TGA list-medicine labelling guidance expects. Most legitimate sellers resolve this kind of discrepancy before the order ships, so it is a rare consumer-side issue.
7 · Block 5 — Batch identifier and expiry window
The batch and expiry lines are the smallest text on the pack, but they carry the most consumer-side accountability. Two fields to look for:
- Batch identifier (Lot) — the alphanumeric code that ties the bottle in your hand to the manufacturing record.
- Expiry date (EXP) — the latest month and year the product remains usable at the labelled storage conditions.
A once-daily routine across a 120-capsule pack covers roughly four months of use, so the expiry window on a freshly-shipped pack typically extends well beyond the expected end of that four-month period. Storing the pack in a cool, dry place following the on-pack storage note keeps the batch within its labelled limits until the consumer reaches the last sub-pack.
If the batch identifier is missing or the expiry print is faint, this is the simplest offline reason to contact the sponsor on the Official Information Center page before opening the inner seal.
8 · 4 × 30 sub-pack design — what each sub-pack tells you
The LDV20 pack is presented as 120 capsules split into 4 × 30 sub-packs, as recorded on the Official Information Center. The sub-pack design carries three consumer-side advantages worth reading directly off the box:
- Each sub-pack is independently labelled. The AUST L number, batch identifier and expiry window appear on each sub-pack, so a consumer opening only one sub-pack at a time still has every label field in view.
- Each sub-pack covers roughly one month of routine. At one capsule per day, a 30-capsule sub-pack supports the dose routine printed on the product page for the whole month.
- Sub-pack boundaries give the routine a built-in check-in. Every 30 capsules is a natural point to re-read the directions and confirm the routine is still aligned with the label wording.
The sub-pack design is a routine convenience that not every listed medicine in the same category offers. Reading the four sub-packs line-up alongside the labelled expiry is the most useful way to plan the routine horizon in advance.
9 · Pack-to-routine mapping table
Pulling the five blocks together, the table below maps each on-pack line to the once-daily routine the LDV20 product page describes. The mapping is the everyday correspondence a routine can be set against:
| On-pack line | What it tells the routine |
|---|---|
| Product name: LDV20 | Single-product identifier — keep one product family per routine slot |
| AUST L 502251 | Reconcile against the public ARTG entry on first reading |
| Four ingredients by botanical / chemical name | The four-pathway frame (cardiovascular, metabolic, hepatic, macronutrient) |
| Sugar cane wax alcohols 20 mg | Cardiovascular anchor at the listed-medicine maximum daily amount |
| Sponsor: Pure Australia | The Australian entity legally responsible for the listed-medicine entry |
| Standard AUST L advisory wording | Always read the label; consult a healthcare professional where the pack directs |
| Directions for use (once daily with food) | The product-page routine — pair the capsule with the same meal each day |
| Batch identifier | Ties the bottle in hand to the manufacturing record |
| Expiry window | Plan the routine horizon — a 120-capsule pack covers roughly four months at one capsule per day |
| 4 × 30 sub-pack design | One sub-pack covers roughly one month — a natural check-in point |
| Storage note | Cool, dry place — keep the pack in the same visible spot to anchor the next dose |
This mapping is the entire LDV20 review condensed to a single table. Reading it before the inner seal is opened turns the outside of the box into a one-line summary of the inner routine.
10 · Frequently Asked Questions
Where is the AUST L number printed on the LDV20 pack?
It appears within the standard TGA labelling code block. For LDV20 the number reads AUST L 502251.
How do I read the four ingredients on the LDV20 pack?
By botanical and chemical name: Berberis aristata, chromic chloride hexahydrate, sugar cane wax alcohols and Silybum marianum. The same four names appear on the public ARTG entry.
What does the sponsor line on the pack mean?
The sponsor line names the Australian-listed entity legally responsible for the listed-medicine entry. For LDV20 the sponsor is Pure Australia, recorded on the TGA sponsor record.
Where is the standard AUST L advisory wording on the pack?
It is printed inside the standardised advisory block that every Australian listed medicine is required to carry, as set out on the TGA labelling and presentation guidance page.
Why is the pack split into 4 × 30 sub-packs?
It is a routine-convenience design that maps each sub-pack to roughly one month of the once-daily routine printed on the LDV20 product page. Each sub-pack carries its own AUST L number, batch identifier and expiry line.
What should I do if the pack label is missing the AUST L number?
Return the unopened pack to the seller. Under the TGA label code, every label must include the AUST L number.
Where do I find the official manufacturer information?
On the LDV20 Official Information Center and the LDV20 consumer FAQ, both published by Pure Australia.
11 · References
Australian regulators and public registers
- Therapeutic Goods Administration (TGA) — home
- TGA — Australian Register of Therapeutic Goods (ARTG)
- TGA ARTG — LDV20 (entry 502251)
- TGA sponsor record — Pure Australia
- TGA — AUST numbers on medicine labels
- TGA — Understanding labelling and presentation requirements for listed medicines
- TGA — Listed medicines overview
- TGA — Good Manufacturing Practice (GMP)
- NHMRC — Australian Dietary Guidelines
- Australian Government — Physical Activity and Sedentary Behaviour Guidelines
Ingredient-level supporting literature (public records and reviews)
- Castaño G, et al. (2001) — Policosanol 20 vs 40 mg/day dose-finding study
- 2017 sugarcane-derived policosanol meta-analysis
- Zhao JV, et al. (2021) — Effect of Berberine on Cardiovascular Disease Risk Factors (Nutrients, MDPI)
- Xia LM, et al. (2016) — Study progress of berberine for treating cardiovascular disease
- NCBI Bookshelf — Milk Thistle (StatPearls, 2024)
- NIH Office of Dietary Supplements — Chromium fact sheet for health professionals
Pure Australia internal pages referenced in this article
12 · Editorial disclaimer
This article is published by the Pure Australia Editorial Team for educational and informational purposes. It walks Australian consumers through how to read the LDV20 pack and label, using only publicly registered TGA ARTG fields and the wording published on the LDV20 product page.
This LDV20 review is a consumer-side framework, not a clinical recommendation. References to ingredient-level research relate to those ingredients as individual compounds studied under various research conditions and do not constitute clinical studies conducted on LDV20 itself.
LDV20 is an Australian Listed Medicine entered on the Australian Register of Therapeutic Goods (ARTG) under AUST L 502251.
Always read the label and follow the directions for use. If symptoms persist, worsen, or if you have concerns regarding your health, consult a qualified healthcare professional.